Biocompatible Sorbent for AGE Removal from Bodily Fluids
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Advanced glycation end products (AGEs) accumulate in bodily fluids, leading to degenerative diseases and inflammation, and current methods are inadequate for effectively removing or preventing their progression.
Innovation Solution
A biocompatible sorbent, such as Cytosorb, is used to contact bodily fluids, specifically designed to bind and remove AGEs, utilizing polymers like crosslinked styrene-divinylbenzene copolymers and other macroporous polymers to sequester these harmful compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to treat degenerative diseases, then treatment options are limited, but the accumulation of AGEs continues unchecked
Solution Approach 1:
The sorbent is designed with universal binding capability to remove AGEs from multiple bodily fluids (blood, urine, cerebrospinal fluid) and applies to multiple degenerative diseases simultaneously (diabetes, cardiovascular disease, kidney failure, Alzheimer's), making a single device effective across diverse medical applications
Solution Approach 2:
The invention uses a sorbent with controlled pore structure that selectively binds AGEs through adsorption. The porous material allows the sorbent to access and remove AGEs from bodily fluids while maintaining biocompatibility and avoiding non-specific binding to other molecules
2Object-affected harmful factors
If AGEs are allowed to accumulate, then natural bodily functions are maintained, but degenerative diseases and inflammation increase
Solution Approach 1:
The sorbent selectively extracts and removes AGEs from bodily fluids through adsorption. The sorbent binds to AGEs and separates them from the fluid, effectively reducing AGE concentration while maintaining the integrity of other beneficial substances in the fluid
3Quantity of substance
If a sorbent is introduced to remove AGEs, then AGE concentrations decrease, but the complexity of the treatment system increases
Solution Approach 1:
The sorbent's binding characteristics are optimized by adjusting parameters such as pore size, surface area, and chemical composition. These parameter changes enable the sorbent to selectively bind AGEs while maintaining biocompatibility and avoiding binding to essential proteins or other bodily molecules
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The sorbent effectively removes AGEs from bodily fluids, reducing their inflammatory impact and potentially treating or preventing associated degenerative diseases like diabetes, heart disease, and Alzheimer's, by efficiently binding and removing these compounds, as demonstrated by experiments showing reduced AGE concentrations post-treatment.
Implementation Method 1
contacting the bodily fluid with a sorbent
Data Source
AI summary
The invention concerns removing advanced glycation end products from a bodily fluid by contacting the bodily fluid with a sorbent.